600201 生物股份
已收盘 03-27 15:00:00
资讯
新帖
简况
生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%
证券之星 · 03-26 22:08
生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%
生物股份(600201.SH)子公司取得新兽药注册证书
智通财经 · 03-26 16:04
生物股份(600201.SH)子公司取得新兽药注册证书
异动快报：生物股份（600201）3月23日14点39分触及跌停板
证券之星 · 03-23
异动快报：生物股份（600201）3月23日14点39分触及跌停板
生物股份参投企业 发布首款多智能体桌面管家
证券日报 · 03-19
生物股份参投企业 发布首款多智能体桌面管家
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
证券之星 · 03-18
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%
证券之星 · 02-03
生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%
【机构调研记录】睿远基金调研生物股份
证券之星 · 02-03
【机构调研记录】睿远基金调研生物股份
2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 02-02
2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股
每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份
证券之星 · 02-01
每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份
生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%
证券之星 · 01-27
生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%
生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%
证券之星 · 01-27
生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%
海通国际：首次覆盖生物股份给予增持评级，目标价20.7元
证券之星 · 01-20
海通国际：首次覆盖生物股份给予增持评级，目标价20.7元
每周股票复盘：生物股份（600201）大股东首次增持61.46万股
证券之星 · 01-11
每周股票复盘：生物股份（600201）大股东首次增持61.46万股
开源证券：给予生物股份买入评级
证券之星 · 01-08
开源证券：给予生物股份买入评级
1月6日生物股份发布公告，股东增持61.46万股
证券之星 · 01-06
1月6日生物股份发布公告，股东增持61.46万股
1月5日生物股份涨6.57%，国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 01-05
1月5日生物股份涨6.57%，国泰中证畜牧养殖ETF基金重仓该股
生物股份涨6.57%，开源证券二个月前给出“买入”评级
证券之星 · 01-05
生物股份涨6.57%，开源证券二个月前给出“买入”评级
每周股票复盘：生物股份（600201）现240.04万元大宗交易
证券之星 · 01-02
每周股票复盘：生物股份（600201）现240.04万元大宗交易
生物股份（600201）股东内蒙古金宇生物控股有限公司质押840万股，占总股本0.76%
证券之星 · 2025-12-31
生物股份（600201）股东内蒙古金宇生物控股有限公司质押840万股，占总股本0.76%
12月30日生物股份现240.04万元大宗交易
证券之星 · 2025-12-30
12月30日生物股份现240.04万元大宗交易
加载更多
公司概况
公司名称：
金宇生物技术股份有限公司
所属行业：
医药制造业
上市日期：
1999-01-15
主营业务：
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格：
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":13.96,"timestamp":1774594800000,"preClose":13.66,"halted":0,"volume":21857681,"delay":0,"changeRate":0.022,"floatShares":1112000000,"shares":1112000000,"eps":0.0907,"marketStatus":"已收盘","change":0.3,"latestTime":"03-27 15:00:00","open":13.54,"high":14.14,"low":13.5,"amount":306000000,"amplitude":0.0469,"askPrice":13.96,"askSize":77,"bidPrice":13.95,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.0907,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":13.66,"symbolType":"stock","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":15.03,"lowLimit":12.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":2.84,"roa":"--","peRate":153.914002,"roe":"3.0%","epsLYR":0.1,"committee":0.250542,"marketValue":15520000000,"turnoverRate":0.0197,"status":0,"floatMarketCap":15520000000},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2622866378","title":"生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622866378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622866378?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:08","pubTimestamp":1774534101,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，生物股份报收于13.66元，较前一交易日下跌1.44%，最新总市值为151.86亿元。该股当日开盘13.77元，最高13.92元，最低13.55元，成交额达2.15亿元，换手率为1.41%。近日，生物股份发布关于子公司取得新兽药注册证书的公告。该疫苗用于预防鹅新城疫和小鹅瘟，种鹅免疫产生期为二免后21日，免疫期5个月，雏鹅被动免疫期20日。产品需在2～8℃保存，有效期12个月。上市前需申请兽药产品批准文号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600043903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0185","BK0028","BK0046","BK0239","BK0196","BK0188","BK0077","BK0012"],"gpt_icon":0},{"id":"2622121832","title":"生物股份(600201.SH)子公司取得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622121832","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622121832?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:04","pubTimestamp":1774512272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)公告，公司全资子公司金宇优邦生物科技(江苏)有限公司(简称“金宇优邦”)与其他单位联合研制的鹅新城疫、小鹅瘟二联灭活疫苗(A-VII株+GPVP3/Bac株)获批准为新兽药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物股份(600201.SH)子公司取得新兽药注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","BK0188","BK0012","BK0046","BK0239","BK0077","600201","BK0196","BK0028"],"gpt_icon":0},{"id":"2621672759","title":"异动快报：生物股份（600201）3月23日14点39分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2621672759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621672759?lang=zh_cn&edition=full","pubTime":"2026-03-23 14:40","pubTimestamp":1774248055,"startTime":"0","endTime":"0","summary":"证券之星3月23日盘中消息，14点39分生物股份（600201）触及跌停板。其所属行业动物保健目前下跌。该股为内蒙古概念，宠物经济，人工智能概念热股。3月20日的资金流向数据方面，主力资金净流出2932.8万元，占总成交额5.64%，游资资金净流入1606.35万元，占总成交额3.09%，散户资金净流入1326.45万元，占总成交额2.55%。近5日资金流向一览见下表：生物股份主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300014989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0077","BK0185","BK0012","600201","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2620295233","title":"生物股份参投企业 发布首款多智能体桌面管家","url":"https://stock-news.laohu8.com/highlight/detail?id=2620295233","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620295233?lang=zh_cn&edition=full","pubTime":"2026-03-19 06:33","pubTimestamp":1773873180,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 近日，国内动物保健行业的龙头企业金宇生物技术股份有限公司，在人工智能领域的战略布局再结硕果。3月18日，其参投的厦门星宇智算智能科技有限公司正式发布首款多智能体桌面管家——XyClaw。 据了解，生物股份投资星宇智算，为星宇智算的技术研发与产品落地提供了坚实的资本支持。投资者据此操作，风险自担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-03-19/doc-inhrnktw1039120.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-19/doc-inhrnktw1039120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0185","BK0188","BK0012","BK0046","BK0239","BK0077","600201","BK0196","BK0028"],"gpt_icon":0},{"id":"2620675239","title":"华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620675239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620675239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:21","pubTimestamp":1773825667,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司持有华兰基因多少比例的股份？华兰生物回复：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800029977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0188","BK0046","600201","002007","BK0196","BK0012","BK0077","BK0028","BK0185","BK0239"],"gpt_icon":0},{"id":"2608887293","title":"生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608887293?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:04","pubTimestamp":1770127491,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，生物股份报收于16.42元，较前一交易日上涨0.86%，最新总市值为182.55亿元。近日，金宇生物技术股份有限公司发布公告称，持股5%以上股东内蒙古金宇生物控股有限公司持有公司股份125,510,800股，占公司总股本的11.29%。本次解除质押后，生物控股累计质押公司股份15,820,000股，占其所持股份的12.60%，占公司总股本的1.42%。生物控股及其一致行动人合计持有公司股份154,647,368股，占公司总股本的13.91%；本次解除质押后累计质押股份占其合计持股的10.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300042778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0012","BK0046","600201","BK0185","BK0028","BK0188","BK0196"],"gpt_icon":0},{"id":"2608204819","title":"【机构调研记录】睿远基金调研生物股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608204819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608204819?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:13","pubTimestamp":1770077629,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及2月2日披露的机构调研信息，睿远基金近期对1家上市公司进行了调研，相关名单如下：1）生物股份 调研纪要：公司于2025年7月取得非洲猪瘟亚单位疫苗临床批件，10月启动田间试验，2026年1月23日完成首次攻毒试验，计划2026年4月启动第二轮攻毒试验，6月完成临床数据分析并提交报告，争取早日实现产业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300006756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0077","600201","BK0046","BK0185","BK0188","BK0196","BK0239"],"gpt_icon":0},{"id":"2608085992","title":"2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608085992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608085992?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:31","pubTimestamp":1770021115,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日生物股份跌9.81%，收盘报16.28元，换手率6.66%，成交量74.05万手，成交额12.55亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为59.49亿元，最新净值0.6414，较上一交易日上涨0.25%，近一年上涨16.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","516670","BK0012","600201","BK0028","BK0196","BK0077","BK0185","BK0046","BK0188"],"gpt_icon":0},{"id":"2608077072","title":"每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077072","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077072?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:09","pubTimestamp":1769882950,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，生物股份报收于18.05元，较上周的17.35元上涨4.03%。本周关注点公司公告汇总：股东内蒙古金宇生物控股有限公司质押7,420,000股，占公司总股本3.10%公司公告汇总生物股份关于股东股份质押的公告金宇生物技术股份有限公司股东内蒙古金宇生物控股有限公司持有公司股份125,474,300股，占公司总股本的11.29%。本次质押后累计质押股份数量为34,420,000股，占其所持股份的27.43%，占公司总股本的3.10%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","600201","BK0185","BK0196","BK0077","BK0012","BK0046"],"gpt_icon":0},{"id":"2606623788","title":"生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623788?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:31","pubTimestamp":1769509872,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份1月27日公开信息显示，股东内蒙古金宇生物控股有限公司向浙商证券股份有限公司合计质押742.0万股，占总股本0.67%。质押详情见下表：截止本公告日，股东内蒙古金宇生物控股有限公司已累计质押股份3442.0万股，占其持股总数的28.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700033089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0012","BK0196","BK0239","BK0188","BK0185","BK0077","600201"],"gpt_icon":0},{"id":"2606020522","title":"生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606020522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606020522?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:32","pubTimestamp":1769506377,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，生物股份报收于18.5元，较前一交易日上涨2.04%，最新总市值为205.67亿元。该股当日开盘18.26元，最高18.96元，最低17.9元，成交额达11.42亿元，换手率为5.57%。公告显示，公司股东内蒙古金宇生物控股有限公司持有公司股份125,474,300股，占公司总股本的11.29%。本次将其持有的7,420,000股无限售流通股质押给浙商证券股份有限公司，用于融资周转。本次质押后累计质押股份数量为34,420,000股，占其所持股份的27.43%，占公司总股本的3.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700029741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0012","BK0196","BK0077","BK0046","BK0185","BK0188","600201"],"gpt_icon":0},{"id":"2604016157","title":"海通国际：首次覆盖生物股份给予增持评级，目标价20.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604016157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604016157?lang=zh_cn&edition=full","pubTime":"2026-01-20 14:06","pubTimestamp":1768889160,"startTime":"0","endTime":"0","summary":"海通国际证券集团有限公司Yidan Lin近期对生物股份进行研究并发布了研究报告《主业走出谷底，关注非瘟疫苗进展》，首次覆盖生物股份给予增持评级，目标价20.7元。生物股份(600201)本报告导 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260120/c674152985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600201"],"gpt_icon":0},{"id":"2602354065","title":"每周股票复盘：生物股份（600201）大股东首次增持61.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354065","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602354065?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:12","pubTimestamp":1768072330,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，生物股份报收于17.4元，较上周的15.07元上涨15.46%。本周，生物股份1月9日盘中最高价报17.56元，股价触及近一年最高点。股本股东变化股东增减持1月6日，股东内蒙古金宇生物控股有限公司增持生物股份61.46万股，占公司总股本的0.0553%，成交金额约983.22万元。本次增持为2025年12月24日披露的增持计划的首次实施，计划期间为2025年12月24日至2026年12月23日，拟增持金额5000万元至1亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0077","600201","BK0046","BK0185","BK0188","BK0196","BK0239"],"gpt_icon":0},{"id":"2601368479","title":"开源证券：给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601368479","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601368479?lang=zh_cn&edition=full","pubTime":"2026-01-08 18:32","pubTimestamp":1767868379,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司陈雪丽,王高展近期对生物股份进行研究并发布了研究报告《公司深度报告：非瘟亚单位疫苗全球首发在即，创新龙头成长动能强劲》，给予生物股份买入评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800032121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2601982598","title":"1月6日生物股份发布公告，股东增持61.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601982598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601982598?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:32","pubTimestamp":1767691951,"startTime":"0","endTime":"0","summary":"证券之星消息，1月6日生物股份发布公告《生物股份:生物股份关于大股东首次增持公司股份暨增持计划实施进展的公告》，其股东内蒙古金宇生物控股有限公司于2026年1月6日合计增持61.46万股，占公司目前总股本的0.0553%，变动期间该股股价上涨0.25%，截止1月6日收盘报16.1元。股东增减持详情见下表：根据生物股份2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600029153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","BK0077","BK0188","BK0028","BK0012","BK0185","600201","BK0046"],"gpt_icon":0},{"id":"2601100515","title":"1月5日生物股份涨6.57%，国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601100515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601100515?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:31","pubTimestamp":1767598294,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日生物股份涨6.57%，收盘报16.06元，换手率4.98%，成交量55.33万手，成交额8.85亿元。重仓生物股份的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元，最新净值0.6319，较上一交易日下跌0.75%，近一年上涨11.41%。该公募基金现任基金经理为梁杏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0196","600201","BK0028","BK0188","BK0077","516670","BK0185","BK0239","BK0046"],"gpt_icon":0},{"id":"2601059290","title":"生物股份涨6.57%，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601059290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601059290?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:31","pubTimestamp":1767598286,"startTime":"0","endTime":"0","summary":"今日生物股份涨6.57%，收盘报16.06元。2025年10月28日，开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告：业绩修复向上，非瘟疫苗临床实验有序推进》，该研报对生物股份给出“买入”评级。公司业绩修复向上，非瘟疫苗研发加速，新品多点开花持续成长，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为16.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2600036184","title":"每周股票复盘：生物股份（600201）现240.04万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036184","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036184?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:04","pubTimestamp":1767294252,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，生物股份报收于15.34元，较上周的14.97元上涨2.47%。本周，生物股份12月23日盘中最高价报16.9元。本周关注点交易信息汇总：生物股份12月30日发生240.04万元大宗交易。本次质押后，生物控股累计质押公司股份数量为27,000,000股，占其持股总数的22.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","600201","BK0046","BK0028","BK0185","BK0196","BK0239","BK0077"],"gpt_icon":0},{"id":"2595877325","title":"生物股份（600201）股东内蒙古金宇生物控股有限公司质押840万股，占总股本0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595877325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595877325?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:42","pubTimestamp":1767177731,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份12月31日公开信息显示，股东内蒙古金宇生物控股有限公司向中国民生银行股份有限公司呼和浩特分行合计质押840.0万股，占总股本0.76%。质押详情见下表：截止本公告日，股东内蒙古金宇生物控股有限公司已累计质押股份2700.0万股，占其持股总数的22.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100035204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0012","BK0077","600201","BK0185","BK0239","BK0196","BK0046"],"gpt_icon":0},{"id":"2595934267","title":"12月30日生物股份现240.04万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2595934267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595934267?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:42","pubTimestamp":1767087774,"startTime":"0","endTime":"0","summary":"证券之星消息，12月30日生物股份发生大宗交易，交易数据如下：大宗交易成交价格16.23元，相对当日收盘价溢价8.2%，成交14.79万股，成交金额240.04万元，买方营业部为国联民生证券股份有限公司浙江分公司，卖方营业部为财通证券股份有限公司杭州金城路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1479.0手，溢价成交1笔。截至2025年12月30日收盘，生物股份报收于15.0元，下跌2.53%，换手率3.55%，成交量39.43万手，成交额5.96亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000029871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0196","BK0239","BK0028","BK0046","BK0188","BK0077","600201","BK0012"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774600611238,"stockEarnings":[{"period":"1week","weight":-0.0789},{"period":"1month","weight":-0.1436},{"period":"3month","weight":-0.1095},{"period":"6month","weight":0.4625},{"period":"1year","weight":0.8552},{"period":"ytd","weight":-0.0936}],"compareEarnings":[{"period":"1week","weight":-0.0293},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0188},{"period":"6month","weight":0.0159},{"period":"1year","weight":0.1545},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49033人(较上一季度减少10.70%)","perCapita":"22673股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}